RNS

Released : August 14, 2020 07:00   RNS Number : 1154W MaxCyte, Inc. 14 August 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Aug 14, 2020
Released : July 16, 2020 18:04   RNS Number : 2766T MaxCyte, Inc. 16 July 2020       MaxCyte, Inc. ("MaxCyte" or the "Company")   Director Dealings and Issue of Equity   Gaithersburg, Maryland - 16 July 2020:   MaxCyte (LSE: MXCT, MXCS), the global cell-based medicines and life sciences company,
Jul 16, 2020
Released : July 15, 2020 07:00   RNS Number : 0040T MaxCyte, Inc. 15 July 2020         MaxCyte, Inc. ("MaxCyte" or the "Company")   Trading Update   ·    First-half revenues at $10.9m delivering growth of 30% year-on-year ·    Launch of expanded new ExPERT ™ range of disposables to broaden
Jul 15, 2020
Released : July 08, 2020 07:00   RNS Number : 3179S MaxCyte, Inc. 08 July 2020                                   FOR IMMEDIATE RELEASE   APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401   APEIRON to utilize MaxCyte's ExPERT® platform for siRNA-based
Jul 08, 2020
Released : July 01, 2020 07:00   RNS Number : 5842R MaxCyte, Inc. 01 July 2020   SCHEDULE 6 AIM BLOCK ADMISSION RETURN / TOTAL VOTING RIGHTS   Please ensure the entries on this return are typed   a. Name of company   MaxCyte, Inc.   b. Name of scheme(s)   MaxCyte Long Term Incentive Plan   c.
Jul 01, 2020
Released : June 02, 2020 17:54   RNS Number : 7382O MaxCyte, Inc. 02 June 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Jun 02, 2020
Released : May 28, 2020 15:34   RNS Number : 2665O MaxCyte, Inc. 28 May 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
May 28, 2020
Released : May 26, 2020 17:49   RNS Number : 9875N MaxCyte, Inc. 26 May 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
May 26, 2020
Released : May 26, 2020 16:22   RNS Number : 9750N MaxCyte, Inc. 26 May 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
May 26, 2020
Released : May 26, 2020 15:45   RNS Number : 9712N MaxCyte, Inc. 26 May 2020   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
May 26, 2020